CSF3 and neutropenia: To manage neutropenia, 35 patients (42.2%) received granulocyte colony-stimulating factor (G-CSF) as primary prophylaxis starting on day 2 or 3 of cycle 1 due to a prior history of neutropenia or febrile neutropenia.